focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 493.70
Bid: 494.10
Ask: 494.20
Change: -3.30 (-0.66%)
Spread: 0.10 (0.02%)
Open: 497.00
High: 498.00
Low: 493.10
Prev. Close: 497.00
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

27 Nov 2023 12:00

RNS Number : 7828U
Aviva PLC
27 November 2023

27 November 2023

Publication of Final Terms pursuant to the issue of £500m Dated Tier 2 Fixed Rate Reset Notes due 27 November 2053 by Aviva plc (the "Company")

The following Final Terms have been filed with the Financial Conduct Authority (the "FCA") and are available for viewing:

Final Terms dated 27 November 2023 (the "Final Terms") relating to the issue by the Company of £500m Dated Tier 2 Fixed Rate Reset Notes due November 2053 under the £7,000,000,000 Euro Note Programme (the "Programme") of the Company updated on 16 June 2023. The Programme enables the Company to issue debt instruments, including a range of subordinated securities.

The Final Terms should be read in conjunction with the Base Prospectus dated 16 June 2023, as supplemented by a Supplemental Prospectus dated 11 September 2023 and a Supplemental Prospectus dated 17 November 2023 (together the "Prospectus").

To view the Final Terms, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/7828U_1-2023-11-27.pdf

Copies of the following documents are also available from the websites listed below:

Base Prospectus approved by the FCA on 16 June 2023 relating to the Programme

https://static.aviva.io/content/dam/aviva-corporate/documents/investors/pdfs/credit-investors/Aviva-EMTN-MTN-Prospectus-2023.pdf

Supplemental Prospectus approved by the FCA on 11 September 2023 relating to the Programme

https://static.aviva.io/content/dam/aviva-corporate/documents/investors/pdfs/credit-investors/Aviva-2023-Supplementary-Prospectus.pdf

Supplemental Prospectus approved by the FCA on 17 November 2023 relating to the Programme

https://static.aviva.io/content/dam/aviva-corporate/documents/investors/pdfs/credit-investors/Aviva-2023-Supplementary-Prospectus-Q3.pdf

The Base Prospectus, the Supplemental Prospectuses and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and are available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Enquiries:

Media:

Andrew Reid +44 (0)7800 694 276

Sarah Swailes +44 (0)7800 694 859

Analysts:

Rupert Taylor Rea +44 (0)7385 494 440

Michael O'Hara +44 (0)7387 234 388

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to United States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States (as defined in Regulation S under the Securities Act) or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder). The Prospectus may not be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
PFTFDLFLXFLFFBX
Date   Source Headline
30th Nov 202310:00 amRNSTotal Voting Rights
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20231:25 pmRNSForm 8.3 - Forward Partners Group PLC
28th Nov 20231:20 pmRNSForm 8.3 - Molten Ventures PLC
27th Nov 202312:00 pmRNSPublication of Final Terms
27th Nov 20237:00 amRNSAviva to acquire Optiom
22nd Nov 20234:45 pmRNSHolding(s) in Company
22nd Nov 20234:02 pmRNSHolding(s) in Company
21st Nov 202310:11 amRNSStabilisation Notice
20th Nov 202310:07 amRNSStabilisation Notice
17th Nov 202312:04 pmRNSPublication of Suppl.Prospcts
16th Nov 20232:22 pmRNSTR-1: Notification of major holdings
16th Nov 20237:00 amRNSAviva plc Q3 2023 Trading Update
15th Nov 20232:46 pmRNSDirector/PDMR Shareholding
15th Nov 20239:24 amRNSAviva plc - Provisional 2024 Financial Calendar
15th Nov 20239:21 amRNSDividend Declaration
14th Nov 202312:00 pmRNSHolding(s) in Company
10th Nov 20234:57 pmRNSHolding(s) in Company
10th Nov 20239:40 amRNSHolding(s) in Company
6th Nov 20233:45 pmRNSHolding(s) in Company
2nd Nov 202311:39 amRNSHolding(s) in Company
1st Nov 202311:11 amRNSRedemption – 0.625 per cent. Senior Notes
31st Oct 20239:53 amRNSTotal Voting Rights
17th Oct 20239:54 amRNSDirector/PDMR Shareholding
17th Oct 20239:50 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSInvestor and Analyst briefing on Wealth Business
16th Oct 20235:34 pmRNSHolding(s) in Company
12th Oct 20233:00 pmRNSDirector/PDMR Shareholding
11th Oct 20233:40 pmRNSTR-1: Notification of major holdings
10th Oct 20232:42 pmRNSDirector/PDMR Shareholding
2nd Oct 20234:30 pmRNSHolding(s) in Company
29th Sep 202310:53 amRNSTotal Voting Rights
28th Sep 20232:48 pmRNSDirector/PDMR Shareholding
26th Sep 20232:40 pmRNSHolding(s) in Company
26th Sep 202312:00 pmRNSDirector/PDMR Shareholding
25th Sep 20231:29 pmRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSAviva to acquire AIG's protection business
22nd Sep 20233:40 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20237:00 amRNSHolding(s) in Company
15th Sep 20233:24 pmRNSHolding(s) in Company
15th Sep 20231:09 pmRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSDisposal
11th Sep 20233:29 pmRNSEMTN Supplementary Prospectus
31st Aug 20239:42 amRNSTotal Voting Rights
23rd Aug 20231:14 pmRNSDirector/PDMR Shareholding
18th Aug 20232:25 pmRNSTR-1: Notification of major holdings
17th Aug 20239:57 amRNSDirector/PDMR Shareholding
16th Aug 20233:50 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.